ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Thailand’s PTT Chemical and Israel’s Ben-Gurion University of the Negev are joining to develop green algae strains. The pair intend to use mutant strains of Parietochloris incisa algae developed by BGU to produce dihomo-γ-linolenic acid, a precursor in the manufacture of prostaglandin E1, an anti-inflammatory agent. In the future, the partners aim to develop biofuels from green algae. Last month, PTT announced a $60 million investment in Myriant Technologies, a U.S. company that is building the world’s largest biobased succinic acid facility (C&EN, Jan. 31, page 28).
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter